New kidney stone drug shows promise in early trial
Disease control
Completed
This study tested an experimental drug called LLX-424 in 51 adults who have had kidney stones before. The drug aims to lower oxalate levels in urine, which can help prevent new stones from forming. Participants took either the drug or a placebo for 8 weeks, and researchers checke…
Phase: PHASE2 • Sponsor: Lilac Therapeutics, Inc. • Aim: Disease control
Last updated May 25, 2026 19:18 UTC